Gilead Seeks Supreme Court Review of FCA Claims in Whistleblower Suit

Drug Industry Daily
Gilead asked the Ninth Circuit Court of Appeals to put its ruling reviving a whistleblower suit against the drugmaker on hold while the company petitions the United States Supreme Court to hear the case.

To View This Article:


Subscribe To Drug Industry Daily